These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25576665)

  • 1. Determinants of immunodominance for CD4 T cells.
    Kim A; Sadegh-Nasseri S
    Curr Opin Immunol; 2015 Jun; 34():9-15. PubMed ID: 25576665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous antigens bind MHC class II first, and are processed by cathepsins later.
    Sadegh-Nasseri S; Kim A
    Mol Immunol; 2015 Dec; 68(2 Pt A):81-4. PubMed ID: 26254987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of immunodominant epitopes during antigen processing is hierarchical.
    Sadegh-Nasseri S; Kim A
    Mol Immunol; 2019 Sep; 113():115-119. PubMed ID: 30146122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteases, processing, and thymic selection.
    Cresswell P
    Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085
    [No Abstract]   [Full Text] [Related]  

  • 6. MHC Class II Auto-Antigen Presentation is Unconventional.
    Sadegh-Nasseri S; Kim A
    Front Immunol; 2015; 6():372. PubMed ID: 26257739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights in antigen processing and epitope selection: development of novel immunotherapeutic strategies for cancer, autoimmunity and infectious diseases.
    Haque A; Blum JS
    J Biol Regul Homeost Agents; 2005; 19(3-4):93-104. PubMed ID: 16602623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
    Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
    J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.
    Becker HJ; Kondo E; Shimabukuro-Vornhagen A; Theurich S; von Bergwelt-Baildon MS
    Eur J Haematol; 2016 Aug; 97(2):166-74. PubMed ID: 26561366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of productive antigen-processing activity for MHC class II presentation in macrophages.
    von Delwig A; Musson JA; Shim HK; Lee JJ; Walker N; Harding CV; Williamson ED; Robinson JH
    Scand J Immunol; 2005 Sep; 62(3):243-50. PubMed ID: 16179011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.
    Shim HK; Musson JA; Harper HM; McNeill HV; Walker N; Flick-Smith H; von Delwig A; Williamson ED; Robinson JH
    Immunology; 2006 Nov; 119(3):385-92. PubMed ID: 16919002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partnering for the major histocompatibility complex class II and antigenic determinant requires flexibility and chaperons.
    Sadegh-Nasseri S
    Curr Opin Immunol; 2021 Jun; 70():112-121. PubMed ID: 34146954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources.
    Kim A; Hartman IZ; Poore B; Boronina T; Cole RN; Song N; Ciudad MT; Caspi RR; Jaraquemada D; Sadegh-Nasseri S
    Nat Commun; 2014 Nov; 5():5369. PubMed ID: 25413013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The invariant chain transports TNF family member CD70 to MHC class II compartments in dendritic cells.
    Zwart W; Peperzak V; de Vries E; Keller AM; van der Horst G; Veraar EA; Geumann U; Janssen H; Janssen L; Naik SH; Neefjes J; Borst J
    J Cell Sci; 2010 Nov; 123(Pt 21):3817-27. PubMed ID: 20971706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
    de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
    Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.
    von Delwig A; Musson JA; Gray J; McKie N; Robinson JH
    Immunology; 2005 Feb; 114(2):194-203. PubMed ID: 15667564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.
    Niazi KR; Ochoa MT; Sieling PA; Rooke NE; Peter AK; Mollahan P; Dickey M; Rabizadeh S; Rea TH; Modlin RL
    Immunology; 2007 Dec; 122(4):522-31. PubMed ID: 17635609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing of viable Salmonella typhimurium for presentation of a CD4 T cell epitope from the Salmonella invasion protein C (SipC).
    Musson JA; Hayward RD; Delvig AA; Hormaeche CE; Koronakis V; Robinson JH
    Eur J Immunol; 2002 Sep; 32(9):2664-71. PubMed ID: 12207351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of viable group A streptococci leads to major histocompatibility complex class II presentation of T cell epitopes from the major protective antigen.
    Rossiter BA; Alfonso C; Kehoe MA; Robinson JH
    Eur J Immunol; 1994 May; 24(5):1244-7. PubMed ID: 7514136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.